The good Dr T on the front foot again (apologies if its already been posted):
PharmAust CEO Dr Michael Thurn spoke with Ashtyn Hiron from Sto_khe_d about the Phase 1 clinical trial of the drug monepantel (MPL) in patients with motor neurone disease (MND/ALS).
https://lnkd.in/gDdPB882
Ann: Options Offer to Existing Listed Option Holders, page-51
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.32M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 391728 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 45800 | 3 |
View Market Depth
| Last trade - 10.22am 01/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |
Day chart unavailable